Talaromycosis marneffei of the Cervical Spine: An Unusual Infection

J Am Acad Orthop Surg Glob Res Rev. 2021 Jun 9;5(6). doi: 10.5435/JAAOSGlobal-D-21-00003.

Abstract

Talaromyces marneffei infection (TMI) causing vertebral osteomyelitis of the cervical spine is extremely rare. TMI in an HIV-uninfected patient is also unusual. This report presents the successful treatment of an HIV-uninfected TMI patient who underwent C6 and T1 vertebrectomies, bone grafting, and anterior cervical plating accompanied by antifungal therapy. A 63-year-old woman was diagnosed with adult-onset immune deficiency. She suddenly developed progressive neck pain without neurologic deficit. The plain radiographs and magnetic resonance imaging showed inflammation and abscess formation along the prevertebral area from C3-4 to T2-3 with vertebral body destruction. Intraoperative pus culture and tissue specimens were determined to be T marneffei. The patient was treated intravenously with amphotericin B deoxycholate for 4 weeks (0.6 mg/kg/d) and oral itraconazole (400 mg/d) for 12 months. Over a 2 consecutive year follow-up period, she achieved a full recovery with an absence of neck pain.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antifungal Agents / therapeutic use
  • Cervical Vertebrae / diagnostic imaging
  • Female
  • Humans
  • Middle Aged
  • Mycoses
  • Talaromyces*

Substances

  • Antifungal Agents

Supplementary concepts

  • Talaromyces marneffei
  • talaromycosis